SCHEMBL21667281

SCHEMBL21667281

CCn1c(=O)cc(NCc2cccc(C(F)(F)F)c2)[nH]c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.53
▸ ADORA2B P29275 1/20 0.44
▸ KCNN3 Q9UGI6 1/20 0.44
▸ P2RX7 Q99572 1/20 0.43
▸ CHEK1 O14757 1/20 0.43
▸ DAPK3 O43293 1/20 0.43
▸ ROCK2 O75116 1/20 0.43
▸ RPS6KA5 O75582 1/20 0.43
▸ CHEK2 O96017 1/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ PRKACA P17612 1/20 0.43
▸ RPS6KB1 P23443 1/20 0.43
▸ AKT1 P31749 1/20 0.43
▸ AKT2 P31751 1/20 0.43
▸ CLK2 P49760 1/20 0.43
▸ GSK3A P49840 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ RPS6KA3 P51812 1/20 0.43
▸ CSNK1G2 P78368 1/20 0.43
▸ PRKAA1 Q13131 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21667344 0.91 EGFR (0.54) EGFRADORA2BKCNN3P2RX7CHEK1
SCHEMBL21667342 0.84 GRIN1 (0.52) EGFRADORA2BP2RX7CHEK1DAPK3
SCHEMBL21667387 0.83 PGR (0.47) P2RX7MEN1KMT2A
SCHEMBL21667215 0.82 SMN1; SMN2 (0.53) KDM4ENPSR1MEN1CYP1A2GAA
SCHEMBL21667218 0.79 KMT2A (0.42) DAOMEN1GAAKMT2AMAPT
SCHEMBL16321171 0.78 HTT (0.49) DAOCNR1CYP3A4
SCHEMBL16321172 0.78 HTT (0.49) DAOCNR1CYP3A4
SCHEMBL21667384 0.75 GPR84 (0.45) ADORA2BDAOKDM4EMEN1CYP1A2
SCHEMBL21667214 0.74 SMN1; SMN2 (0.47) KDM4ENPSR1MEN1KMT2AMAPT
SCHEMBL21667382 0.73 ADORA1 (0.49) DAOMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3702352-A1 PYRIMIDINEDIONE COMPOUND AGAINST CARDIAC CONDITIONS Myokardia, Inc. (US) 2020-09-02 — — EP disclosed
EP-3010910-B1 PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS MYOKARDIA INC (US) 2020-02-05 — — EP disclosed
Send feedback